Salah A. Aly’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


Fig. 1. Workflow Diagram
Fig. 2. The implementation process
Fig. 3. Data samples before and after image segmentation. (a) Before segmentation and (b) After segmentation.
Fig. 5. YOLOv11n accuracy with SGD
Fig. 9. YOLOv11n accuracy with AdamW

+8

Acute Lymphoblastic Leukemia Diagnosis Employing YOLOv11, YOLOv8, ResNet50, and Inception-ResNet-v2 Deep Learning Models
  • Preprint
  • File available

February 2025

·

58 Reads

Alaa Awad

·

Salah A. Aly

Thousands of individuals succumb annually to leukemia alone. As artificial intelligence-driven technologies continue to evolve and advance, the question of their applicability and reliability remains unresolved. This study aims to utilize image processing and deep learning methodologies to achieve state-of-the-art results for the detection of Acute Lymphoblastic Leukemia (ALL) using data that best represents real-world scenarios. ALL is one of several types of blood cancer, and it is an aggressive form of leukemia. In this investigation, we examine the most recent advancements in ALL detection, as well as the latest iteration of the YOLO series and its performance. We address the question of whether white blood cells are malignant or benign. Additionally, the proposed models can identify different ALL stages, including early stages. Furthermore, these models can detect hematogones despite their frequent misclassification as ALL. By utilizing advanced deep learning models, namely, YOLOv8, YOLOv11, ResNet50 and Inception-ResNet-v2, the study achieves accuracy rates as high as 99.7%, demonstrating the effectiveness of these algorithms across multiple datasets and various real-world situations.

Download

Fig. 2: Performance metrics for YOLOv11s. (a) Train loss, (b) Accuracy, and (c) Validation loss.
Fig. 3: Normalized confusion matrix for YOLOv11s.
Early Diagnoses of Acute Lymphoblastic Leukemia Using YOLOv8 and YOLOv11 Deep Learning Models

October 2024

·

272 Reads

Thousands of individuals succumb annually to leukemia alone. This study explores the application of image processing and deep learning techniques for detecting Acute Lymphoblastic Leukemia (ALL), a severe form of blood cancer responsible for numerous annual fatalities. As artificial intelligence technologies advance, the research investigates the reliability of these methods in real-world scenarios. The study focuses on recent developments in ALL detection, particularly using the latest YOLO series models, to distinguish between malignant and benign white blood cells and to identify different stages of ALL, including early stages. Additionally, the models are capable of detecting hematogones, which are often misclassified as ALL. By utilizing advanced deep learning models like YOLOv8 and YOLOv11, the study achieves high accuracy rates reaching 98.8%, demonstrating the effectiveness of these algorithms across multiple datasets and various real-world situations.